GemmaCert Secures $2.25M in Series A-1 Funding

GemmaCert, a Tel Aviv, Israel-based provider of cannabis analysis technology platform, completed a $2.25M in Series A-1 funding round.

The round, which brings total funding to over $3m, was led by NEO Ventures, Stony Hill, and Arba Finance, combined with additional seed funding from Aggrinovation.

The company intends to use the new capital to accelerate the execution of its business development plans, boost talent recruitment generate first revenues in 2018.

Led by Dr. Guy Setton, Co-Founder and CEO, and Oded Shoseyov, co-founder and Chief Scientific Officer, GemmaCert provides a non-destructive desktop cannabis composition and potency testing solution primarily for professional and home growers, processors and dispensaries. GemmaCert is an eco-friendly device that combines advanced optics and algorithms to analyze whole dry cannabis flower buds, ground cannabis samples and cannabis oils in about 30 seconds.



Join the discussion